Randall S. Davis - Concepedia

Author

Randall S. Davis

University of Alabama at Birmingham ORCID

Also Known As

R Davis, R S Davis, R. Davis, R. S. Davis, RANDALL S. DAVIS, Randall Davis, Randall S Davis, Randall S. Davis, Randall S. Davis, Reuben Davis

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham Howard Hughes Medical Institute Huntsman Cancer Institute Sidney Kimmel Comprehensive Cancer Center University of Utah

About

Randall S. Davis is an author at University of Alabama at Birmingham specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.2K
2	Allergy	3	3	394
3	Education	1	1	24
4	Natural Sciences	1	1	87
5	Nursing	1	1	24

Randall S. Davis

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells Götz R. A. Ehrhardt, Joyce T. Hsu, Lanier Gartland, The Journal of Experimental Medicine Distinctive Tissue-based PopulationImmunologyHumoral ResponseImmunologic MechanismCd4 T Cell Responses	2005	335
Identification of a family of Fc receptor homologs with preferential B cell expression Randall S. Davis, Yui‐Hsi Wang, Hiromi Kubagawa, Proceedings of the National Academy of Sciences	2001	215
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement Douglas B. Johnson, Mellissa J. Nixon, Yu Wang, JCI Insight ImmunologyImmunoeditingImmunologic MechanismAntigen ProcessingImmunotherapy	2018	155
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. William G. Wierda, John C. Byrd, Jeremy S. Abramson, PubMed Hematological MalignancyLymphoid NeoplasiaVersion 4.2020Chronic Lymphocytic LeukemiaMedicine	2020	143
The inhibitory potential of Fc receptor homolog 4 on memory B cells Götz R. A. Ehrhardt, Randall S. Davis, Joyce T. Hsu, Proceedings of the National Academy of Sciences	2003	124
FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling Hae Won Sohn, P. Krueger, Randall S. Davis, Blood	2011	107
Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment Christopher L. Haga, Götz R. A. Ehrhardt, Rebecca J. Boohaker, Proceedings of the National Academy of Sciences	2007	104
IgEb immune complexes activate macrophages through FcγRIV binding Masayuki Hirano, Randall S. Davis, W D Fine, Nature Immunology ImmunologyImmunologic MechanismImmunoglobulin EInnate ImmunityMedicine	2007	94
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019 William G. Wierda, John C. Byrd, Jeremy S. Abramson, Journal of the National Comprehensive Cancer Network Hematological MalignancyTumor BiologyLymphoid NeoplasiaHodgkin LymphomaMedicine	2019	94
Tumor Suppression by Phospholipase C-β3 via SHP-1-Mediated Dephosphorylation of Stat5 Wenbin Xiao, Hong Hong, Yuko Kawakami, Cancer Cell Signal TransductionSignaling PathwayBiochemistryNatural SciencesTumor Suppression	2009	87

Page 1